http://geriatrics.modernmedicine.com/geriatrics Medicine for Midlife & Beyond. Geriatrics is a peer-reviewed journal dedicated to providing primary care physicians with information on the care of patients over the age of 45. This award-winning journal features in-depth clinical reviews, relevant abstracts from the top 50 medical research journals, medical meeting summaries and Continuing Medical Education articles from which physicians can earn AMA Category 1 credits. 2008-07-09T01:31:31Z http://geriatrics.modernmedicine.com/geriatrics/Geriatric-health-care--managing-the-crisis/ArticleStandard/Article/detail/528198?ref=25 5-minute consult 2008-07-01T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/282008/528198/Hammerschlag_thumbnail.gif http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/282008/528198null HTML http://geriatrics.modernmedicine.com/geriatrics/GERIATRICS/Case-Asymptomatic-slowly-enlarging-facial-lesion/ArticleStandard/Article/detail/524115?ref=25 Consider sebaceous tumors such as sebaceous epithelioma in yellow lesions on the face 2008-06-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/252008/524115null XML http://geriatrics.modernmedicine.com/geriatrics/Research+Briefs/Investigational-prostate-cancer-drug-deemed-safe-i/ArticleStandard/Article/detail/524128?ref=25 An investigational drug for advanced prostate cancer that attempts to target a drug directly to the tumor is safe and shows some signs of efficacy at higher doses. 2008-06-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/252008/524128null XML http://geriatrics.modernmedicine.com/geriatrics/Research+Briefs/Thiazolidinediones-may-raise-risk-of-hip-wrist-fra/ArticleStandard/Article/detail/524124?ref=25 Patients with diabetes who take the oral insulin-sensitizing drugs rosiglitazone and pioglitazone may be at an increased risk of suffering hip and wrist fractures. 2008-06-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/252008/524124null XML http://geriatrics.modernmedicine.com/geriatrics/Research+Briefs/Variant-alleles-predispose-to-osteoporosis-and-fra/ArticleStandard/Article/detail/524131?ref=25 Individuals of European descent who possess variant alleles of genes regulating bone metabolism have an increased risk of osteoporosis and osteoporotic fractures. 2008-06-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/252008/524131null XML http://geriatrics.modernmedicine.com/geriatrics/Research+Briefs/Tarenflurbil-shows-some-promise-in-mild-Alzheimers/ArticleStandard/Article/detail/524126?ref=25 In patients with mild Alzheimer's disease, the selective amyloid-beta-42 lowering agent tarenflurbil may slow declines in activities of daily living and global function. 2008-06-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/252008/524126null XML http://geriatrics.modernmedicine.com/geriatrics/Research+Briefs/Diastolic-blood-pressure-predicts-survival-for-cor/ArticleStandard/Article/detail/524121?ref=25 Diastolic blood pressure is an independent predictor of long-term survival after hospital discharge in patients with acute coronary syndromes. 2008-06-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/252008/524121null XML http://geriatrics.modernmedicine.com/geriatrics/Research+Briefs/Grapefruit-flavonoid-effective-against-hepatitis-C/ArticleStandard/Article/detail/524130?ref=25 Naringenin, one of the most abundant flavonoids in grapefruit and other citrus fruits, may be a novel treatment for hepatitis C. 2008-06-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/252008/524130null XML http://geriatrics.modernmedicine.com/geriatrics/Research+Briefs/Inflammation-albuminuria-predict-heart-failure/ArticleStandard/Article/detail/524120?ref=25 Markers of inflammation and albuminuria serve as predictors of congestive heart failure, and the association between obesity and the condition may be related to inflammation. 2008-06-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/252008/524120null XML http://geriatrics.modernmedicine.com/geriatrics/Research+Briefs/Health-behaviors-vary-among-cancer-survivors/ArticleStandard/Article/detail/524127?ref=25 Though only a minority of cancer survivors are meeting standard recommendations for exercise and fruit and vegetable consumption, most are abstaining from smoking. 2008-06-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/252008/524127null XML http://geriatrics.modernmedicine.com/geriatrics/GERIATRICS/Physicians-are-not-required-to-hire-certified-code/ArticleStandard/Article/detail/524116?ref=25 Are physicians required to hire certified coders? 2008-06-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/252008/524116null XML http://geriatrics.modernmedicine.com/geriatrics/GERIATRICS/Out-of-office-protimes-monitoring-is-not-billable/ArticleStandard/Article/detail/524117?ref=25 Can out-of-office protimes monitoring be billed? 2008-06-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/252008/524117null XML http://geriatrics.modernmedicine.com/geriatrics/geri.com+exclusives/Balancing-the-risks-benefits-of-ESAs-in-treating-a/ArticleStandard/Article/detail/524494?ref=25 Although erythropoiesis-stimulating agents have been used effectively to treat certain anemias for nearly two decades, several developments have prompted warnings regarding their use in cancer and chronic kidney failure. 2008-06-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/252008/524494/Geri0608_rotate_flash.gif XML http://geriatrics.modernmedicine.com/geriatrics/GERIATRICS/Anemia-Balancing-the-risks-benefits-of-erythropoie/ArticleStandard/Article/detail/524112?ref=25 Although erythropoiesis-stimulating agents have been used effectively to treat certain anemias for nearly two decades, several developments have prompted the US Food and Drug Administration to issue warnings regarding their use in cancer and chronic kidney failure, essential knowledge for practicing physicians in all settings. 2008-06-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/252008/524112null XML http://geriatrics.modernmedicine.com/geriatrics/GERIATRICS/A-practical-approach-to-guide-clinicians-in-the-ev/ArticleStandard/Article/detail/524113?ref=25 Many clinicians find themselves questioning how to evaluate male patients with breast complaints. Most symptoms such as pain or enlargement can be caused by various benign processes such as gynecomastia, sebaceous cysts, lipomas, hematomas, or excess adipose tissue. However, the presence of a breast mass may lead to concerns about breast cancer, which must be excluded as a diagnostic possibility. 2008-06-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/252008/524113null XML http://geriatrics.modernmedicine.com/geriatrics/GERIATRICS/Medical-Editor-Dr-Fredrick-Sherman-on-geriatricizi/ArticleStandard/Article/detail/524129?ref=25 In a 2003 editorial, I chided the US Senate Special Committee on Aging, whose members' median age was then 57, to train more health care providers in geriatrics so that distinguished group of Boomers would get better care when they got old. Not much happened! It's now 5 years later and the recently released Retooling for an Aging America: Building the Health Care Workforce tells the nation what it must do -- again. 2008-06-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/252008/524129/Fred-Sherman_thumbnail.gif http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/252008/524129null XML http://geriatrics.modernmedicine.com/geriatrics/Research+Briefs/High-blood-pressure-causes-millions-of-premature-d/ArticleStandard/Article/detail/524132?ref=25 There are 7.6 million premature deaths worldwide each year attributable to high blood pressure, and half of all strokes and cases of ischemic heart disease are attributable to the condition. 2008-06-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/252008/524132null XML http://geriatrics.modernmedicine.com/geriatrics/Fully-searchable-access-to-complete-June-2008-issu/ArticleStandard/Article/detail/524469?ref=25 Erythropoiesis-stimulating agents in anemia Evaluation of breast masses in older men Recognizing and managing depression at the end of life Plus regular columns and departments 2008-06-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/252008/524469/geri0608_CV_thumbnail.gif http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/252008/524469null REMOTE http://geriatrics.modernmedicine.com/geriatrics/Research+Briefs/Hormone-therapy-increases-stroke-risk-despite-timi/ArticleStandard/Article/detail/524123?ref=25 In postmenopausal women, hormone therapy is associated with a significantly increased risk of stroke regardless of the type of regimen or the timing of therapy initiation. 2008-06-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/252008/524123null XML http://geriatrics.modernmedicine.com/geriatrics/GERIATRICS/Treating-depression-in-terminally-ill-patients-can/ArticleStandard/Article/detail/524114?ref=25 Patients facing terminal illness often also face psychological distress, and the co-occurrence of depression and anxiety with the physical effects of chronic disease can increase morbidity for elderly persons and hasten death. Screening for depression in terminally ill patients can optimize their physical comfort at the end of life and provide them the opportunity to confront and prepare for death. 2008-06-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/252008/524114null XML http://geriatrics.modernmedicine.com/geriatrics/Research+Briefs/Exercise-key-to-maintaining-long-term-weight-loss-/ArticleStandard/Article/detail/524125?ref=25 While caloric restriction leads to short-term weight loss, increases in physical activity may be necessary to overcome the body's tendency to re-establish the original body weight and prevent weight regain. 2008-06-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/252008/524125null XML http://geriatrics.modernmedicine.com/geriatrics/GERIATRICS/Nurse-practitioner-can-bill-under-a-physicians-num/ArticleStandard/Article/detail/524118?ref=25 When can a nurse practitioner bill under a physician's number? 2008-06-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/252008/524118null XML http://geriatrics.modernmedicine.com/geriatrics/Research+Briefs/Dementia-risk-profiles-differ-for-men-and-women/ArticleStandard/Article/detail/524122?ref=25 Men and women have different risk profiles for mild cognitive impairment and progression to dementia. 2008-06-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/252008/524122null XML http://geriatrics.modernmedicine.com/geriatrics/GERIATRICS/Pre-op-history-and-physical-can-be-billed/ArticleStandard/Article/detail/524119?ref=25 When can pre-op history and physical be billed? 2008-06-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/252008/524119null XML http://geriatrics.modernmedicine.com/geriatrics/Gut-hormones-key-to-appetite-regulation/ArticleStandard/Article/detail/522686?ref=25 Gut hormones play a key and often overlooked role in weight loss and weight regulation. Changes in weight are determined largely by the balance between energy intake and energy expenditure, but gut hormones can affect both sides of the energy equation. 2008-06-09T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/242008/522686null HTML http://geriatrics.modernmedicine.com/geriatrics/Hyperglycemia-can-affect-NO-pathway-of-endothelial/ArticleStandard/Article/detail/522683?ref=25 Hyperglycemia is involved in the dysregulation of endothelial nitric oxide (NO) synthase, leading to endothelial dysfunction and an increased risk of vasculopathy, said Markku Laakso, MD. 2008-06-09T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/242008/522683null HTML http://geriatrics.modernmedicine.com/geriatrics/Surrogate-endpoints-in-drug-approval-process-exami/ArticleStandard/Article/detail/522680?ref=25 Surrogate endpoints in clinical trials (ie, hemoglobin [Hb] A1c) on which drug approvals may be based only explain narrow aspects of complex conditions. For this reason, even when using a drug as labeled, there is always a level of uncertainty over outcomes with the drug, said Saul Malozowski, MD, PhD, MPH. 2008-06-09T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/242008/522680null HTML http://geriatrics.modernmedicine.com/geriatrics/Separate-drug-classes-prevent-development-of-type-/ArticleStandard/Article/detail/522679?ref=25 Pioglitazone prevented progression to type 2 diabetes in patients with impaired glucose tolerance (IGT), reported Ralph DeFronzo, MD. The effect was marked?81% fewer patients assigned to pioglitazone compared with placebo converted from IGT to type 2 diabetes in a randomized, double-blind, placebo-controlled clinical study. 2008-06-09T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/242008/522679null HTML http://geriatrics.modernmedicine.com/geriatrics/Endovascular-interventions-for-PAD-proliferate/ArticleStandard/Article/detail/522684?ref=25 The range of endothelial interventions for peripheral artery disease (PAD) is proliferating. Today's choices include traditional balloon angioplasty, stents, drug eluting stents and fabric-covered stents. Newer technologies allow clinicians to cut out occlusions, freeze them, scrape them, laser them and kill them. 2008-06-09T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/242008/522684null HTML http://geriatrics.modernmedicine.com/geriatrics/Basal-insulin-plus-pramlintide-at-mealtimecontrols/ArticleStandard/Article/detail/522682?ref=25 Pramlintide injection added to basal insulin at mealtime is similar to titrated rapid-acting insulin in achieving glycemic control but with a lower risk of hypoglycemia and no weight gain in patients with type 2 diabetes, said Matthew Riddle, MD, head, section of diabetes, division of endocrinology/diabetes/clinical nutrition, Oregon Health and Sciences University, Portland. 2008-06-09T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/242008/522682null HTML http://geriatrics.modernmedicine.com/geriatrics/Coronary-and-aortic-calcium-burden-strongly-predic/ArticleStandard/Article/detail/522685?ref=25 Coronary artery calcium and abdominal aortic calcium both predicted future cardiovascular events in a Veterans Administration population with type 2 diabetes. The relationship between calcium scores and cardiovascular events was independent of standard cardiovascular risk factors, said Peter Reaven, MD. 2008-06-09T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/242008/522685null HTML http://geriatrics.modernmedicine.com/geriatrics/Be-wary-of-trace-element-claims/ArticleStandard/Article/detail/522681?ref=25 Clinicians should be wary of health claims made for trace elements such as iron or chromium. While there is no doubt that trace elements are needed for health, there is significant doubt about their utility in preventing or curing diabetes and other diseases, said Eliseo Guallar, MD, DrPH, Johns Hopkins Bloomberg School of Public Health, Baltimore. There are many hypotheses about the beneficial effects of trace elements, but little high-quality data, little reliable population data, few useful biomarkers, relatively crude analytical methods and few mechanistic studies. 2008-06-09T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/242008/522681null HTML http://geriatrics.modernmedicine.com/geriatrics/ACCORD-trial-reveals-increased-risk-of-death/ArticleStandard/Article/detail/522423?ref=25 An intense glucose-lowering strategy in high-risk patients with type 2 diabetes was associated with an excess of mortality in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) trial, the U.S. counterpart to the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation) study. 2008-06-08T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/242008/522423null HTML http://geriatrics.modernmedicine.com/geriatrics/Pedal-osteolysis-can-be-biomarker-for-diabetic-dis/ArticleStandard/Article/detail/522422?ref=25 Current research suggests that pedal osteolysis, the loss of bone mineral density (BMD) in the foot, may be a useful biomarker for Charcot's arthropathy and other diabetic foot diseases. 2008-06-08T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/242008/522422null HTML http://geriatrics.modernmedicine.com/geriatrics/Putting-weight-loss-into-clinical-practice/ArticleStandard/Article/detail/522424?ref=25 Translating weight loss research into clinical programs is not easy. Too many clinical protocols exist in isolation, according to Donald Williamson, PhD, Pennington Biomedical Research Center, Baton Rouge, LA. The key gap is extending methods that contribute to weight loss into programs that maintain weight loss. 2008-06-08T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/242008/522424null HTML http://geriatrics.modernmedicine.com/geriatrics/Diabetic-atherosclerotic-disease-evolves-in-stages/ArticleStandard/Article/detail/522426?ref=25 Atherosclerosis and its complications develop in stages. Each of each of these stages is affected by different metabolic abnormalities, said Scott Grundy, MD, PhD, during the annual Edwin Bierman lecture. 2008-06-08T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/242008/522426null HTML http://geriatrics.modernmedicine.com/geriatrics/Novel-agents-for-glycemic-control-are-under-invest/ArticleStandard/Article/detail/522421?ref=25 Several novel classes of agents designed to treat hyperglycemia are under investigation. These agents were the subjects of a symposium here. One such novel class is the sodium glucose co-transporter (SGLT) type 2 inhibitors, which reduce glucose levels by increasing kidney excretion of glucose. The kidney plays an important role in the handling of glucose, said Robert R. Henry, MD, professor of medicine and chief of VA endocrinology and metabolism at the University of California, San Diego. SGLT-2 is expressed almost exclusively in the kidney. About 90% of glucose reabsorption by the kidney is mediated by SGLT-2 under normal circumstances. 2008-06-08T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/242008/522421null HTML http://geriatrics.modernmedicine.com/geriatrics/UK-study-Subpar-glycemic-control-associated-with-p/ArticleStandard/Article/detail/522425?ref=25 British women who have poorer glycemic control before and during pregnancy have poorer outcomes and less-healthy babies. That's the take home message from CEMACH, the Confidential Enquiry into Maternal and Child Health, a year-long survey of pregnant women with type 1 and type 2 diabetes across the United Kingdom. 2008-06-08T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/242008/522425null HTML http://geriatrics.modernmedicine.com/geriatrics/Reducing-excess-iron-levels-encourages-diabetic-wo/ArticleStandard/Article/detail/522379?ref=25 Researchers at Stanford University are reporting positive results in healing diabetic wounds with a pharmaceutical agent already approved by the FDA, but only in mice so far. 2008-06-07T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/522379null HTML http://geriatrics.modernmedicine.com/geriatrics/2008+AAD+Meeting+Highlights/Human-factors-make-or-break-continuous-glucose-mon/ArticleStandard/Article/detail/522384?ref=25 Real-time continuous glucose monitoring (CGM) can significantly improve glycemic control, but it will not help all patients. "Real-time CGM will add significantly to glucose management for some people, but not for all," said Irl Hirsch, MD, University of Washington, Seattle. "Human factors make all the difference between success and failure. Some patients will never figure it out. That?s why real-time control is so challenging. 2008-06-07T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/522384null HTML http://geriatrics.modernmedicine.com/geriatrics/2008+AAD+Meeting+Highlights/Type-2-diabetes-increases-fracture-risk-to-minor-d/ArticleStandard/Article/detail/522385?ref=25 The risk of fracture is probably only slightly increased in persons with type 2 diabetes, said Peter Vestergaard, MD, PhD, DrMedSc, from the Osteoporosis Clinic, Aarhus Amtssygehus, Denmark. 2008-06-07T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/522385null HTML http://geriatrics.modernmedicine.com/geriatrics/2008+AAD+Meeting+Highlights/Hepatic-steatosis-new-worry-in-type-2-diabetes/ArticleStandard/Article/detail/522378?ref=25 Clinicians and type 2 diabetes patients have a new worry: hepatic steatosis, or nonalcoholic fatty liver disease. Liver disease is a less-obvious problem than kidney disease but may have equally grave consequences. 2008-06-07T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/522378null HTML http://geriatrics.modernmedicine.com/geriatrics/Progress-is-rapid-in-islet-cell-transplants/ArticleStandard/Article/detail/522381?ref=25 Islet cell transplants are effective in both the short- and long-term in freeing patients with diabetes from insulin injections and have proven to be safe, said Bernhard J. Hering, MD. The use of embryonic pig pancreatic precursor tissue as the source of islets appears promising and would expand the number of transplant recipients, which is currently limited by number of potential donors. 2008-06-07T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/522381null HTML http://geriatrics.modernmedicine.com/geriatrics/GLP-1-secretion-No-acute-affect-on-insulin/ArticleStandard/Article/detail/522380?ref=25 Take another look at the popular hypothesis that suggests type 2 diabetes has an acute effect on the secretion of GLP-1 and that lower GLP-1 secretion has an acute effect on insulin. It doesn't work that way, said Michael Nauck, MD, PhD, Diabeteszentrum Bad Lauterberg, Bad Lauterberg, Germany. Decreased GLP-1 secretion is not part of the pathophysiology of type 2 diabetes. 2008-06-07T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/522380null HTML http://geriatrics.modernmedicine.com/geriatrics/2008+AAD+Meeting+Highlights/Pharmacologic-options-for-painful-diabetic-neuropa/ArticleStandard/Article/detail/522383?ref=25 Good glycemic control is not sufficient to relieve painful diabetic neuropathy, necessitating investigation of other modalities to achieve analgesic efficacy. Dan Ziegler, MD, German Diabetes Clinic, German Diabetes Center, and professor of internal medicine, Leibniz Institute at the Heinrich Heine University, Düsseldorf, provided an overview of pharmacologic treatments that have been explored for painful diabetic neuropathy and the success achieved with each. 2008-06-07T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/522383null HTML http://geriatrics.modernmedicine.com/geriatrics/Evidence-suggests-that-treating-periodontal-diseas/ArticleStandard/Article/detail/522346?ref=25 Periodontal disease makes glycemic control more difficult in patients with type 2 diabetes, said George W. Taylor, DrPH, DMD, associate professor of dentistry, School of Dentistry and Public Health at the University of Michigan, Ann Arbor. 2008-06-06T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/522346null HTML http://geriatrics.modernmedicine.com/geriatrics/Greetings-from-the-ADA-in-San-Francisco/ArticleStandard/Article/detail/522214?ref=25 The editorial teams in the Modern Medicine Primary Care Content Group, with content from our legacy brands — Medical Economics, Drug Topics, Geriatrics, Formulary and Contemporary OB/Gyn — will cover key medical meetings, bringing you breaking news, the latest research findings and reports from the general sessions. 2008-06-06T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/522214null HTML http://geriatrics.modernmedicine.com/geriatrics/ADVANCE-Intensive-blood-glucose-control-has-renal-/ArticleStandard/Article/detail/522347?ref=25 Intensive blood glucose control in patients with type 2 diabetes resulted in a significant reduction in the risk of microvascular complications compared with standard blood glucose control. This was driven by a reduction in the occurrence of nephropathy, in the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) study. 2008-06-06T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/522347null HTML http://geriatrics.modernmedicine.com/geriatrics/Endothelial-dysfunction-in-diabetes-is-marker-caus/ArticleStandard/Article/detail/522348?ref=25 Endothelial dysfunction is both a marker for and a cause of diabetic complications. Researchers are teasing out pathways that involve oxidative stress and endothelial dysfunction, said Per-Henrik Groop, MD, PhD, Helsinki University Central Hospital, Helsinki, Finland. The challenge is in finding drugs that show the same activity in vivo that they show in cell studies or animal models. 2008-06-06T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/522348null HTML http://geriatrics.modernmedicine.com/geriatrics/Exercise-trumps-fit-and-fat-in-diabetes/ArticleStandard/Article/detail/522349?ref=25 Forget the arguments over fit and fat in the development of diabetes and the resulting complications. Both fitness and fatness can be addressed by the same prescription: physical activity. 2008-06-06T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/522349null HTML http://geriatrics.modernmedicine.com/geriatrics/ASCO+2008+Meeting+Highlights/Paroxetine-ineffective-for-insomnia-treatment-in-p/ArticleStandard/Article/detail/520865?ref=25 Physicians treating cancer-related depression with paroxetine should not expect patients' insomnia to also improve, according to a study presented by Oxana G. Palesh, PhD, University of Rochester Cancer Center, NY. "We know that insomnia and depression often occur together frequently in the general population, suggesting that there may be a common mechanism," she said. 2008-06-02T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/520865null HTML http://geriatrics.modernmedicine.com/geriatrics/ASCO+2008+Meeting+Highlights/Aerobic-and-strength-exercise-program-improves-sev/ArticleStandard/Article/detail/520866?ref=25 An individualized exercise program may significantly reduce fatigue, increase strength, and improve psychosocial functioning during cancer treatment, according to results of a small study reported by Maike de Wit, University Clinic Hamburg, Germany. 2008-06-02T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/520866null HTML http://geriatrics.modernmedicine.com/geriatrics/ASCO+2008+Meeting+Highlights/MRI-added-to-mammography-identifies-most-ductal-co/ArticleStandard/Article/detail/520861?ref=25 Magnetic resonance imaging (MRI) is superior to mammography alone in diagnosing intraductal components of invasive breast cancer, allowing more accurate mapping before breast conservation surgery, said Simone Schrading, MD, Department of Radiology, University of Bonn, Germany. 2008-06-02T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/520861null HTML http://geriatrics.modernmedicine.com/geriatrics/ASCO+2008+Meeting+Highlights/Prophylactic-anticoagulation-guidelines-developed-/ArticleStandard/Article/detail/520863?ref=25 Ambulatory patients with cancer who are undergoing chemotherapy should not receive prophylactic anticoagulation to prevent venous thromboembolism, according to new guidelines developed by ASCO. "It's not cost effective and we also do not recommend screening these patients for thrombophilia," said Mark Levine, MD, McMaster University, Hamilton, Ontario, Canada. 2008-06-02T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/520863null HTML http://geriatrics.modernmedicine.com/geriatrics/ASCO+2008+Meeting+Highlights/Metformin-may-have-antitumor-effects/ArticleStandard/Article/detail/520860?ref=25 Metformin may represent a novel antitumor agent, say investigators from the University of Texas M.D. Anderson Cancer Center, Houston. 2008-06-02T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/520860null HTML http://geriatrics.modernmedicine.com/geriatrics/ASCO+2008+Meeting+Highlights/Disparities-in-cancer-care-addressed-solutions-off/ArticleStandard/Article/detail/520862?ref=25 Several factors contribute to a disparity of cancer care and outcomes between minority and majority populations in the United States. 2008-06-02T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/520862null HTML http://geriatrics.modernmedicine.com/geriatrics/ASCO+2008+Meeting+Highlights/Clinicians-too-cautious-in-use-of-chemotherapy-for/ArticleStandard/Article/detail/520864?ref=25 Advanced age should not be a barrier to initiating adjuvant chemotherapy in patients with stage III colon cancer. In an observational study, the oldest patients suffered no more adverse events when treated with adjuvant chemotherapy than did younger patients but were much less likely than their younger counterparts to actually receive adjuvant chemotherapy for their colon cancer, said Katherine L. Khan, MD, professor of medicine at the University of California, Los Angeles. 2008-06-02T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/520864null HTML http://geriatrics.modernmedicine.com/geriatrics/ASCO+2008+Meeting+Highlights/Fatigue-affects-broad-range-of-activities-among-pa/ArticleStandard/Article/detail/520867?ref=25 Cancer-related fatigue significantly interferes with patients' quality of life, and some areas often affected among these patients are not normally included on standard quality-of-life assessments, said Karen M. Mustian, PhD, University of Rochester School of Medicine, NY. More randomized, controlled trials are needed to identify these areas, she said. 2008-06-02T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/520867null HTML http://geriatrics.modernmedicine.com/geriatrics/ASCO+2008+Meeting+Highlights/Acupuncture-demonstrates-promise-in-treating-sympt/ArticleStandard/Article/detail/520458?ref=25 A small study suggests that acupuncture has the potential to reduce pain and dysfunction in patients with head and neck cancer who have undergone neck dissection, said David G. Pfister, MD, chief, Head and Neck Medical Oncology, Memorial Sloan Kettering Cancer Center, New York. 2008-06-01T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/520458null HTML http://geriatrics.modernmedicine.com/geriatrics/ASCO+2008+Meeting+Highlights/Use-of-ESAs-should-be-restricted-to-indications-ex/ArticleStandard/Article/detail/520454?ref=25 Strict evidence-based criteria should be used when prescribing erythropoiesis-stimulating agents (ESAs) for cancer, as ESAs appear to activate signaling pathways that are important in altering tumor behavior and treatment response, experts said. 2008-06-01T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/520454null HTML http://geriatrics.modernmedicine.com/geriatrics/ASCO+2008+Meeting+Highlights/Concomitant-medications-aging-related-changes-in-d/ArticleStandard/Article/detail/520455?ref=25 Drug-drug and disease-drug interactions in elderly patients with cancer are significant; 33% of elderly patients who are taking 3 or more medications are rehospitalized within 6 months of a hospital discharge. "A better index of predicting tolerance to chemotherapy in the elderly is crucial," said Mihaela Popa, MD, Moffitt Cancer Center, Tampa, Florida. Tolerance to chemotherapy among older patients with cancer may be affected by multiple chronic conditions requiring multiple medications and aging-related alterations that induce changes in drug distribution, she said. 2008-06-01T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/520455null HTML http://geriatrics.modernmedicine.com/geriatrics/ASCO+2008+Meeting+Highlights/iKRASi-gene-status-predicts-response-to-initial-bi/ArticleStandard/Article/detail/520452?ref=25 Patients with metastatic colorectal cancer are more likely to respond to initial treatment that includes cetuximab if they have nonmutated, wild-type KRAS gene status, reported Eric Van Cutsem, MD, University Hospital Gasthuisberg, Leuven, Belgium. "For the first time in colorectal cancer, we are able to predict which patients are likely to be helped by the new biologics," he said. "KRAS is the first molecular marker for the selection of a targeted therapy in combination with a standard chemotherapy regimen in first-line metastatic colorectal cancer. KRAS testing should be routinely conducted in all colorectal cancer patients immediately after diagnosis to ensure the best treatment strategies for the individual patient." 2008-06-01T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/520452null HTML http://geriatrics.modernmedicine.com/geriatrics/ASCO+2008+Meeting+Highlights/Combined-treatment-benefits-elderly-patients-with-/ArticleStandard/Article/detail/520456?ref=25 Most elderly patients do not receive combined modality treatment (CMT) with both chemotherapy and radiation for locally advanced, non-small cell lung cancer (NSCLC) despite trial data indicating that CMT enhances survival, decreases comorbidities, and is potentially curative. Data presented by Martin J. Edelman, MD, professor of medicine, University of Maryland Greenebaum Cancer Center, Baltimore, indicate that elderly patients receiving chemotherapy followed by concurrent chemotherapy and radiation derive the most significant survival benefit. 2008-06-01T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/520456null HTML http://geriatrics.modernmedicine.com/geriatrics/ASCO+2008+Meeting+Highlights/Experts-discuss-rules-for-access-to-experimental-d/ArticleStandard/Article/detail/520453?ref=25 The extent to which patients should have access to experimental therapies is a hotly contested issue, and courts and regulatory agencies have wrestled with the problems involved when an individual is willing to be treated with unapproved drugs at the potential expense of causing harm not only to the individual but to the clinical trial process itself. 2008-06-01T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/520453null HTML http://geriatrics.modernmedicine.com/geriatrics/ASCO+2008+Meeting+Highlights/High-dose-vitamin-D-relieves-pain-and-fatigue-asso/ArticleStandard/Article/detail/520457?ref=25 High-dose vitamin D supplementation can provide relief of symptoms related to vitamin D deficiency from aromatase inhibitor therapy in postmenopausal women with breast cancer, said Q.J. Khan, MD, Cancer Center of Kansas, Wichita. 2008-06-01T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/520457null HTML http://geriatrics.modernmedicine.com/geriatrics/ASCO+2008+Meeting+Highlights/Blood-assay-may-detect-early-lung-cancer/ArticleStandard/Article/detail/520451?ref=25 An RNA signature present in blood that is highly accurate for detecting prevalent lung cancer can accurately predict the development of lung cancer within the next 2 years 80% of the time, said Thomas Zander, MD, Department of Internal Medicine and the Center for Integrated Oncology, University Clinic Cologne, Germany. "Early detection of lung cancer is a major need, as most patients present for diagnosis at a late stage when there is no chance for cure," Dr Zander said. Two-year survival after a lung cancer diagnosis is approximately 15%. Early detection may therefore be a promising strategy to improve survival rates. 2008-06-01T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/520451null HTML http://geriatrics.modernmedicine.com/geriatrics/Does-Alzheimers-really-exist/ArticleStandard/Article/detail/520459?ref=25 5-minute consult 2008-06-01T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/520459null HTML http://geriatrics.modernmedicine.com/geriatrics/ONLINE+EXCLUSIVE/Martha-Stewart-adds-her-voice-RealPlayer-Video/ArticleStandard/Article/detail/520571?ref=25 Businesswoman and author Martha Stewart testifies on the role of family caregivers in providing essential services and support to loved ones at U.S. Senate Special Committee on Aging hearing in which Congress reviews the Institute of Medicine's major recommendations for improving and expanding the skills and preparedness of the health care workforce in its report, Retooling for an Aging America: Building the Health Care Workforce. (requires RealPlayer) 2008-06-01T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/232008/520571null REMOTE http://geriatrics.modernmedicine.com/geriatrics/ASCO+2008+Meeting+Highlights/Bevacizumab-Docetaxel-Combination-IsEffective-Firs/ArticleStandard/Article/detail/520315?ref=25 Phase III trial results show that adding bevacizumab to the taxane chemotherapy agent docetaxel as first-line therapy for newly diagnosed HER2-negative, locally recurrent, or metastatic breast cancer resulted in significantly less disease progression. "This shows that the antiangiogenic approach to treating breast cancer is effective, regardless of which taxane drug it is combined with," said lead author David Miles, MD, professor, Mount Vernon Cancer Center, Middlesex, UK. Previous studies have shown that the combination of bevacizumab to paclitaxel doubled progression free survival among metastatic breast cancer patients. 2008-05-31T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/222008/520315null HTML http://geriatrics.modernmedicine.com/geriatrics/ASCO+2008+Meeting+Highlights/Cancer-Is-Independent-Predictor-ofIncreased-Vulner/ArticleStandard/Article/detail/520317?ref=25 Cancer is an independent predictor of increased vulnerability, functional limitations, geriatric syndromes, frailty, and fair or poor health status among older Medicare beneficiaries. "Up until now, a lot of this has been more opinion rather than numbers," said Gary R. Morrow, MD, professor of radiation oncology, University of Rochester Cancer Center. "This gives us a method to let us know if we have changed anything. 2008-05-31T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/222008/520317null HTML http://geriatrics.modernmedicine.com/geriatrics/ASCO+2008+Meeting+Highlights/Vaginal-Brachytherapy-Is-Effective-has-Fewer-Side-/ArticleStandard/Article/detail/520319?ref=25 Vaginal brachytherapy is as effective as external beam radiation therapy in preventing the recurrence of higher-risk endometrial cancer but with fewer side effects and results in superior quality of life, according to a Phase 3 study presented by Remi A. Nout, MD. 2008-05-31T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/222008/520319null HTML http://geriatrics.modernmedicine.com/geriatrics/ASCO+2008+Meeting+Highlights/Intervention-Program-Improves-Sleep-Quality-During/ArticleStandard/Article/detail/520318?ref=25 Adherence to a four-point Individualized Sleep Promotion Plan (ISPP) intervention consisting of stimulus control, sleep restriction, relaxation therapy, and sleep-hygiene practices significantly lowered fatigue and increased sleep quality for patients undergoing adjuvant chemotherapy. Fatigue and sleep disturbances are the most frequently reported symptoms during adjuvant chemotherapy for breast cancer. One-third of breast cancer patients report persistent fatigue and abnormal sleep/wake cycles, said Ann M Berger, PhD, RN, professor, College of Nursing, University of Nebraska Medical Center, Omaha. 2008-05-31T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/222008/520318null HTML http://geriatrics.modernmedicine.com/geriatrics/ASCO+2008+Meeting+Highlights/Everolimus-may-Be-Effective-Second-line-OptionAfte/ArticleStandard/Article/detail/520314?ref=25 Everolimus, an experimental oral agent that targets the mTOR protein, may represent an effective second-line option for patients with metastatic renal-cell carcinoma whose disease has progressed despite treatment with a tyrosine kinase inhibitor. 2008-05-31T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/222008/520314null HTML http://geriatrics.modernmedicine.com/geriatrics/ASCO+2008+Meeting+Highlights/Greetings-from-the-American-Society-of-Clinical-On/ArticleStandard/Article/detail/520311?ref=25 The editorial teams in the Modern Medicine Primary Care Content Group, with content from our legacy brands — Medical Economics, Drug Topics, Geriatrics, Formulary and Contemporary OB/Gyn — will cover key medical meetings, bringing you breaking news, the latest research findings and reports from the general sessions. 2008-05-31T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/222008/520311null HTML http://geriatrics.modernmedicine.com/geriatrics/ASCO+2008+Meeting+Highlights/Modafinil-Appears-to-Alleviate-Chemotherapy-induce/ArticleStandard/Article/detail/520316?ref=25 Modafinil appears to reduce the severity of chemotherapy-induced severe fatigue, reported Gary R. Morrow, PhD, MS. 2008-05-31T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/222008/520316null HTML http://geriatrics.modernmedicine.com/geriatrics/ASCO+2008+Meeting+Highlights/Adjuvant-Zoledronic-Acid-DecreasesBreast-Ca-Recurr/ArticleStandard/Article/detail/520313?ref=25 Adding zoledronic acid to anastrozole or tamoxifen therapy decreased recurrence by 35% and increased disease free survival by 36% in premenopausal breast cancer patients, according to results of the Austrian Breast and Colorectal Cancer Study Group Trial 12 (ABCSG-12). The multicenter, Phase III trial is the first large trial to demonstrate the significant antitumor benefit of zoledronic acid, said Michael Gnant, MD, Medical University of Vienna. "Adjuvant treatment with zoledronic acid should be considered in order to improve the standard of care in premenopausal breast cancer patients," he said. 2008-05-31T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/222008/520313null HTML http://geriatrics.modernmedicine.com/geriatrics/ASCO+2008+Meeting+Highlights/Sunitinib-Recipients-Should-Receive-Cardiac-Monito/ArticleStandard/Article/detail/520312?ref=25 Routine cardiac monitoring is suggested for patients receiving sunitinib, as cardiotoxicity, particularly left ventricular (LV) dysfunction, is common, said Melinda Telli, MD. 2008-05-31T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/222008/520312null HTML http://geriatrics.modernmedicine.com/geriatrics/2008-Geriatrics-Media-Kit/ArticleStandard/Article/detail/520227?ref=25 2008 Geriatrics Media Kit 2008-05-30T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/222008/520227null PDF http://geriatrics.modernmedicine.com/geriatrics/2008-Geriatrics-Rate-Card/ArticleStandard/Article/detail/520222?ref=25 2008 Geriatrics Rate Card 2008-05-30T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/222008/520222null PDF http://geriatrics.modernmedicine.com/geriatrics/2008-Geriatrics-BPA/ArticleStandard/Article/detail/520221?ref=25 2008 Geriatrics BPA 2008-05-30T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/222008/520221null PDF http://geriatrics.modernmedicine.com/geriatrics/CME+Showcase/Parkinsons-Disease-Current-concepts-in-neuroprotec/CME/Article/detail/525391?ref=25 CME activity 2008-05-28T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/cme/geriatrics/262008/525391null REMOTE http://www.modernmedicine.com/modernmedicine/Research+Briefs/Psoriasis-linked-to-multiple-comorbidities/ArticleStandard/Article/detail/516872?ref=25 Patients with psoriasis are likely to have comorbidities that should be addressed with health screening tests, preventative exams and referrals. 2008-05-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/202008/516872null XML http://www.modernmedicine.com/modernmedicine/Research+Briefs/Pioglitazone-reduces-atherosclerotic-burden-compar/ArticleStandard/Article/detail/516875?ref=25 Pioglitazone reduced coronary atherosclerotic burden compared with the sulfonylurea glimepiride in intravascular ultrasound compar-isons in type 2 diabetes patients. 2008-05-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/202008/516875null XML http://www.modernmedicine.com/modernmedicine/Research+Briefs/Barretts-guidelines-update-includes-screening-surv/ArticleStandard/Article/detail/516877?ref=25 With esophageal adenocarcinoma rates rising faster than other cancers, new guidelines are published for diagnosing and treating Barrett's esophagus. 2008-05-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/202008/516877null XML http://geriatrics.modernmedicine.com/geriatrics/Fully-searchable-access-to-complete-May-2008-issue/ArticleStandard/Article/detail/519199?ref=25 Aging complicates both treatment and management of dysphagia Practical tips from a practitioner on delirium's frontlines Managing complications in late Parkinson's Plus regular columns and departments 2008-05-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/222008/519199/geri0608_CV_thumbnail.gif http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/222008/519199null REMOTE http://www.modernmedicine.com/modernmedicine/GERIATRICS/Getting-paid-for-phone-calls-in-home-health-settin/ArticleStandard/Article/detail/516883?ref=25 Q. A previous article stated there was not a way to obtain reimbursement for phone consultation. Do recent changes in Medicare law allow for reimbursement for coordination of care using codes 99339-99340? 2008-05-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/202008/516883null XML http://www.modernmedicine.com/modernmedicine/Research+Briefs/Cerebral-microbleeds-prevalent-in-older-adults/ArticleStandard/Article/detail/516871?ref=25 In older adults, the prevalence of cerebral microbleeds may be significantly higher than commonly believed and risk factors vary according to microbleed location. 2008-05-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/202008/516871null XML http://www.modernmedicine.com/modernmedicine/Research+Briefs/Lifestyle-changes-stress-management-can-reverse-an/ArticleStandard/Article/detail/516873?ref=25 Many patients with coronary artery disease and angina become angina-free after undergoing a lifestyle intervention program. 2008-05-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/202008/516873null XML http://www.modernmedicine.com/modernmedicine/Research+Briefs/Central-obesity-in-midlife-increases-dementia-risk/ArticleStandard/Article/detail/516874?ref=25 Central obesity in midlife appears to increase the risk of dementia in later life, independent of diabetes and other cardiovascular comorbidities. 2008-05-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/202008/516874null XML http://www.modernmedicine.com/modernmedicine/Editorial/Editor-Margaret-Mulligan-on-the-Boomer-surge-and-t/ArticleStandard/Article/detail/516879?ref=25 In 12 years there will be more than 70 million seniors in the U.S. expecting access to high-quality medical care. Compared to their parents, the Boomers have experiences and expectations with health and aging that will create many more demands on the health system and providers. While that may not be all bad, they do have need of some reality checks. 2008-05-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/202008/516879/mulligan_rev_thumbnail.gif http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/202008/516879null XML http://www.modernmedicine.com/modernmedicine/GERIATRICS/Using-modifier--58/ArticleStandard/Article/detail/516882?ref=25 Q. Can you use a modifier "-58" when a patient comes in for postoperative follow-up, and you apply a new cast? 2008-05-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/202008/516882null XML http://www.modernmedicine.com/modernmedicine/GERIATRICS/Billing-for-in-hospital-nurse-practitioner-service/ArticleStandard/Article/detail/516884?ref=25 Q. Can a physician bill for a hospital's nurse practitioner who rounds with his group? 2008-05-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/202008/516884null XML http://www.modernmedicine.com/modernmedicine/GERIATRICS/Practical-tips-for-treating-deliriumbr-/ArticleStandard/Article/detail/518680?ref=25 When elderly patients present with episodes of delirium use several sources of information to clarify baselines and pinpoint chronology of onset of disturbances; be careful about mistaking delirium for depression in hypoactive patients; be certain to assess patients at multiple times of day to notice fluctuations; always inquire about psychosis; be on lookout for "benzodiazepines are bad for old people" approach; control use of prns with education, clear dosing instructions, and monitoring of usage. 2008-05-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/212008/518680null XML http://www.modernmedicine.com/modernmedicine/GERIATRICS/Assessment-treatmentbr-and-management-of-dysphagia/ArticleStandard/Article/detail/518681?ref=25 Dysphagia, or difficulty in swallowing, is a condition with a strong age-related bias. The management and treatment of dysphagia among geriatric patients is complicated by cognitive decline, lowered immunity, malnutrition, and end-of-life decisions. 2008-05-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/212008/518681/geri0508_CVweb_thumbnail.gif http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/212008/518681null XML http://www.modernmedicine.com/modernmedicine/geri.com+exclusives/Assessment-treatment-management-of-dysphagia/ArticleStandard/Article/detail/520310?ref=25 Dysphagia, or difficulty in swallowing, is a condition with a strong age-related bias. Its management and treatment can be complicated by cognitive decline, lowered immunity, malnutrition, and end-of-life decisions. 2008-05-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/222008/520310/DSYPHAGIA_rotate_flash.gif XML http://www.modernmedicine.com/modernmedicine/GERIATRICS/Billing-for-nursing-home-discharge/ArticleStandard/Article/detail/516881?ref=25 Q. If, while in my office, I discharge a patient from a nursing home or skilled nursing facility, can I bill Medicare or the patient for the discharge? 2008-05-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/202008/516881null XML http://www.modernmedicine.com/modernmedicine/Research+Briefs/Coronary-calcification-linked-to-greater-statin-as/ArticleStandard/Article/detail/516869?ref=25 Men with coronary artery calcification are about three times more likely to take statin drugs or aspirin. 2008-05-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/202008/516869null XML http://www.modernmedicine.com/modernmedicine/Research+Briefs/Obesity-reduces-prostate-specific-antigen-levels/ArticleStandard/Article/detail/516870?ref=25 Increasing body mass is associated with a modest reduction in prostate-specific antigen concentrations among men without prostate cancer. 2008-05-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/202008/516870null XML http://www.modernmedicine.com/modernmedicine/Research+Briefs/Kidney-damage-may-lead-to-hypertension/ArticleStandard/Article/detail/516878?ref=25 Hypertension and kidney disease commonly co-exist, and new research points to kidney damage as a risk factor for subsequent hypertension. 2008-05-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/202008/516878null XML http://www.modernmedicine.com/modernmedicine/Research+Briefs/Pulse-wave-velocity-predicts-increases-in-blood-pr/ArticleStandard/Article/detail/516876?ref=25 Pulse wave velocity, a non-invasive index of arterial stiffness, predicts longitudinal increases in blood pressure in hypertensive individuals as well as incident hypertension. 2008-05-15T04:00:00Z http://geriatrics.modernmedicine.com/geriatrics/data/articlestandard/geriatrics/202008/516876null XML